StockData

KALA BIO, Inc. (KALA) stock

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$3.26−0.17 (-4.96%)

Close on Nov 18, 2026Market cap $63.05MP/E –Yield –

Kala Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Kala Bio's market cap was $3.31M on Nov 11, 2026, against $7.18M a year earlier. Over the last 5 years it ranged from $2.93M to $91.25M, with a median of $23.96M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.31M-20.0%
2025Dec 31, 2025$4.13M-87.1%
2024Dec 31, 2024$31.99M+69.7%
2023Dec 29, 2023$18.85M-66.5%
2022Dec 30, 2022$56.33M-28.5%
2021Dec 31, 2021$78.75M-79.3%
2020Dec 31, 2020$380.10M+198.2%
2019Dec 31, 2019$127.47M+5.8%
2018Dec 31, 2018$120.51M-73.2%
2017Dec 29, 2017$450.19M–

More Kala Bio figures

See a number that looks wrong?